AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Novonesis AS Director's Dealing 2014

Feb 28, 2014

3377_rpt_2014-02-28_793bf029-d9d8-4e57-ae82-5273137352e1.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

February 28, 2014

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

Name	Jørgen Buhl Rasmussen
Relation/category of close relation	Board Member
Trading date	28.02.2014
Market	Nasdaq OMX Copenhagen A/S
Character of transaction	Buy of shares
Volume of transaction buy(+)/ sell (-)	+2,000
Value of transaction (DKK)	505,113.00 DKK

Contact information
Investor Relations:
Thomas Bomhoff (DK)	+45 3077 1226	[email protected]
Klaus Sindahl (DK)	+45 5363 0134	[email protected]
Martin Riise (USA)	+1 919 649 2565	[email protected]
Press and media:
Rene Tronborg (DK)	+45 3077 2274	[email protected]
Frederik Bjoerndal (Europe)	+45 3077 0236	[email protected]
Paige Donnelly (USA)	+1 919 218 4501	[email protected]
Meng Lian (China)	+86 136 9923 1164	[email protected]
Henrique Pellini (Brazil)	+55 41 9288 0282	[email protected]
Poonam Kapila (India)	+91 991 082 2339	[email protected]

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Krogshoejvej 36 2880 Bagsvaerd Denmark

Telephone: +45 4446 0000 Email: [email protected] Internet: www.novozymes.com

AI assistant

Novonesis AS — Director's Dealing 2014

3377_rpt_2014-02-28_793bf029-d9d8-4e57-ae82-5273137352e1.pdf

More from Novonesis AS

Novonesis AS Director's Dealing 2014